About DOE Button Organization Button News Button Contact Us Button
Link: Energy home page
Science and Technology Button Energy Sources Button Energy Efficiency Button The Environment Button Prices and Trends Button National Security Button Safety and Health Button
OFFICE OF HEALTH, SAFETY AND SECURITY HEALTH AND SAFETY PROGRAMS
Occupational Medicine
Home
Occupational Medicine Newsletter
Valley Fever Safety Bulletin
Blood Pressure
December Safety
Extreme Weather
Heart Disease Prevention
Minority Health
Mumps
Polio
EFCOG Occ. Med. Spring 2007 Meeting
Site Clinic Directory
Steering Committee Charter
Health and Safety
HSS Logo

 
Text size: Smaller - Normal - Larger - Largest You are Here:  DOE > HSS > HealthSafety

Health Promotion Activities

blue dot image MUMPS

A large outbreak of mumps in the United States began in Iowa in December 2005 and has now affected more than 1500 individuals across the country. Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, Nebraska, and Wisconsin are the predominant states currently investigating reports of mumps. The majority of cases have occurred among persons 18-25 years of age. This current mumps outbreak has raised concern for two reasons. First, mumps usually infects only about 265 people annually in the U.S. Second, this outbreak has affected even those persons who have been previously vaccinated against mumps.

Mumps is a highly contagious viral infection of the salivary glands (primarily the parotid glands). It causes fever, headache, and swelling of the glands around the jaw. This best-known sign, swelling of the glands on one or both sides of the face, is the reason that mumps received its name. Occasionally it can cause more serious complications including meningitis, encephalitis, inflammation of the testicles or ovaries, inflammation of the pancreas, permanent hearing loss, and possibly miscarriage in the first trimester of pregnancy.

Although it is primarily transmitted via coughing and sneezing, mumps may also be transmitted through contact with surfaces contaminated with mucosal secretions. Symptoms typically appear 16 to 18 days after infection, but may appear as soon as 12 days and as long as 25 days afterwards. Infected individuals are contagious up to 3 days before they are symptomatic and continue to be contagious for up to 9 days after showing signs and symptoms. There is no known treatment for mumps beyond supportive care.

The current mumps strain has been identified as genotype G, the same genotype circulating in a similar outbreak in the United Kingdom. The outbreak in the U.K. has been ongoing since 2004, and has involved more than 70,000 cases. The G genotype is not an unusual or rare genotype, and it has been circulating globally for decades or longer. While mumps is normally rare in the U.S., we should be aware that there is the potential for this disease to continue to spread locally through normal human interaction and nationally through air travel.

Cases of mumps involving vaccinated individuals can be attributed to many factors. When a highly vaccinated population is exposed to disease, most cases of disease would be expected to include vaccinated individuals. Even recently vaccinated individuals remain susceptible to infection because it takes 2 to 4 weeks for the newly administered vaccine to provide immunity. Most importantly, no vaccine is 100% effective. Nonetheless, it should be stressed that vaccination for mumps significantly limits the risk of becoming infected with the current genotype G strain and remains an essential step in personal protection.

Since mumps is contagious, it is important to recognize the signs and symptoms of mumps infection: fever, headache, and swelling of the glands around the jaw.

The principal strategy to prevent mumps is vaccination. Mumps can generally be prevented by receiving the MMR vaccine, which is considered to be 90% effective with the recommended 2-dose regimen. In the U.S., health officials recommend that individuals receive 2 mumps vaccinations, the first at 12 to 15 months of age and the second at 4 to 6 years of age. After reviewing their personal health records, individuals should either confirm that they have already received both vaccinations in childhood or make arrangements to get vaccinated as adults (if they are not currently pregnant). Of note, it takes about 2 to 4 weeks after vaccine administration for adequate protective immunity to develop. The duration of the vaccine-induced immunity has been established to be greater than 25 years, and probably life-long in most vaccine recipients.

Avoid close contact with individuals who have mumps-type symptoms, particularly if there is a history of recent travel by that individual to the affected Midwest states. These potentially infected individuals should be considered contagious for 9 days following symptom onset.

For more information, see http://www.cdc.gov/nip/diseases/mumps/default.htm.

For further information please contact:
Claudia Beach
Office of Worker Safety and Health Assistance
301-903-9826


This page was last updated on July 01, 2008


  Security & Privacy Notice   •   HSS Information Inventory   •   HSS Organization                                      
The White House FirstGov.gov FirstGov.gov Spanish Version E-gov IQ FOIA
U.S. Department of Energy | 1000 Independence Ave., SW | Washington, DC 20585
1-800-dial-DOE | f/202-586-4403 |